PhD in mass spectrometry at Uppsala university 2007. Group leader at Cellzome GSK from 2008-2015. Team leader and head of proteomics core facility at EMBL since 2016. The research group at EMBL develops novel proteomic technologies and applies them to study post-translational regulation.